Morphic Holding, Inc. financial data

Symbol
MORF on Nasdaq
Industry
Pharmaceutical Preparations
Location
35 Gatehouse Drive A2, Waltham, MA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Morphic Holding, LLC (to 10/1/2018)
Latest financial report
10-Q - Q2 2024 - Jul 25, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.14K % +9.34%
Debt-to-equity 3.43 % -18.1%
Return On Equity -26.6 % +3.93%
Return On Assets -25.7 % +3.23%
Operating Margin -34.3K % -38207%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50.2M shares +4.8%
Common Stock, Shares, Outstanding 50.1M shares +4.63%
Entity Public Float 2.14B USD +283%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 50.1M shares +18.2%
Weighted Average Number of Shares Outstanding, Diluted 50.1M shares +18.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 166M USD +42.9%
General and Administrative Expense 47.1M USD +33.9%
Costs and Expenses 213M USD +40.8%
Operating Income (Loss) -213M USD -49.4%
Nonoperating Income (Expense) 33.7M USD +154%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -179M USD -38.7%
Income Tax Expense (Benefit) 530K USD +126%
Net Income (Loss) Attributable to Parent -180M USD -38.8%
Earnings Per Share, Basic -3.83 USD/shares -18.9%
Earnings Per Share, Diluted -3.83 USD/shares -19.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 50.8M USD -76.6%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 639M USD -13.9%
Property, Plant and Equipment, Net 2.49M USD -0.88%
Operating Lease, Right-of-Use Asset 3.16M USD +11.4%
Other Assets, Noncurrent 331K USD +68.9%
Assets 646M USD -13.7%
Accounts Payable, Current 7.05M USD +92.5%
Employee-related Liabilities, Current 5.22M USD +20.5%
Accrued Liabilities, Current 4.89M USD +396%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 26.5M USD +48.8%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 1.16M USD -25.5%
Liabilities 27.7M USD +42.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.02M USD +47%
Retained Earnings (Accumulated Deficit) -552M USD -48.3%
Stockholders' Equity Attributable to Parent 618M USD -15.2%
Liabilities and Equity 646M USD -13.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -46.4M USD -47.5%
Net Cash Provided by (Used in) Financing Activities 911K USD -99.1%
Net Cash Provided by (Used in) Investing Activities 31.4M USD
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 50.1M shares +4.63%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.1M USD +18.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 51.4M USD -76.4%
Deferred Tax Assets, Valuation Allowance 144M USD +45.2%
Deferred Tax Assets, Gross 146M USD +43.9%
Operating Lease, Liability 2.34M USD -38.9%
Payments to Acquire Property, Plant, and Equipment 674K USD +22.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -179M USD -38.7%
Lessee, Operating Lease, Liability, to be Paid 2.46M USD -40.9%
Property, Plant and Equipment, Gross 9.04M USD +23.8%
Operating Lease, Liability, Current 2.16M USD +38.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 728K USD -58%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.73M USD +1.88%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 116K USD -64%
Lessee, Operating Lease, Liability, to be Paid, Year Three 728K USD -58%
Deferred Tax Assets, Operating Loss Carryforwards 57.3M USD +14.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 1.17B USD +6.16%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.24M USD -28.1%
Share-based Payment Arrangement, Expense 47.6M USD +37.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%